BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29975360)

  • 1. Clinical picture, pathogenesis and psychometric assessment of negative symptoms of schizophrenia.
    Wójciak P; Rybakowski J
    Psychiatr Pol; 2018 Apr; 52(2):185-197. PubMed ID: 29975360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.
    Kring AM; Gur RE; Blanchard JJ; Horan WP; Reise SP
    Am J Psychiatry; 2013 Feb; 170(2):165-72. PubMed ID: 23377637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tools to assess negative symptoms in schizophrenia.
    Kane JM
    J Clin Psychiatry; 2013 Jun; 74(6):e12. PubMed ID: 23842020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motivation and Pleasure Scale-Self-Report (MAP-SR): Validation of the German version of a self-report measure for screening negative symptoms in schizophrenia.
    Engel M; Lincoln TM
    Compr Psychiatry; 2016 Feb; 65():110-5. PubMed ID: 26773998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Scale for assessing negative symptoms in schizophrenia: A systematic review].
    Mach C; Dollfus S
    Encephale; 2016 Apr; 42(2):165-71. PubMed ID: 26923997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
    Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).
    Valiente-Gómez A; Mezquida G; Romaguera A; Vilardebò I; Andrés H; Granados B; Larrubia J; Pomarol-Clotet E; McKenna PJ; Sarró S; Bernardo M
    Schizophr Res; 2015 Aug; 166(1-3):104-9. PubMed ID: 26116328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric evaluation of the negative syndrome of schizophrenia.
    Garcia-Portilla MP; Garcia-Alvarez L; Saiz PA; Al-Halabi S; Bobes-Bascaran MT; Bascaran MT; Muñiz J; Bobes J
    Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):559-66. PubMed ID: 25802109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polish version of the Self-evaluation of Negative Symptoms (SNS).
    Wójciak P; Górna K; Domowicz K; Jaracz K; Szpalik R; Michalak M; Rybakowski J
    Psychiatr Pol; 2019 Jun; 53(3):551-559. PubMed ID: 31522196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Danish version of the brief negative symptom scale.
    Gehr J; Glenthøj B; Ødegaard Nielsen M
    Nord J Psychiatry; 2019 Oct; 73(7):425-432. PubMed ID: 31407936
    [No Abstract]   [Full Text] [Related]  

  • 11. The Latent Structure of Negative Symptoms in Schizophrenia.
    Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
    JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining and measuring negative symptoms of schizophrenia in clinical trials.
    Marder SR; Kirkpatrick B
    Eur Neuropsychopharmacol; 2014 May; 24(5):737-43. PubMed ID: 24275698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Engel M; Fritzsche A; Lincoln TM
    Psychiatry Res; 2014 Dec; 220(1-2):659-63. PubMed ID: 25138895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Forbes C; Blanchard JJ; Bennett M; Horan WP; Kring A; Gur R
    Schizophr Res; 2010 Dec; 124(1-3):36-42. PubMed ID: 20869848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validation of the French version of the self-evaluation of negative symptoms (SNS)].
    Hervochon C; Bourgeois V; Rotharmel M; Duboc JB; Le Goff B; Quesada P; Campion D; Dollfus S; Guillin O
    Encephale; 2018 Dec; 44(6):512-516. PubMed ID: 29195803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polish version of the Brief Negative Symptom Scale (BNSS).
    Wójciak P; Górna K; Domowicz K; Jaracz K; Gołębiewska K; Michalak M; Rybakowski J
    Psychiatr Pol; 2019 Jun; 53(3):541-549. PubMed ID: 31522195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative symptoms in bipolar disorder and schizophrenia: A psychometric evaluation of the brief negative symptom scale across diagnostic categories.
    Strauss GP; Vertinski M; Vogel SJ; Ringdahl EN; Allen DN
    Schizophr Res; 2016 Feb; 170(2-3):285-9. PubMed ID: 26742510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.
    Blanchard JJ; Bradshaw KR; Garcia CP; Nasrallah HA; Harvey PD; Casey D; Csoboth CT; Hudson JI; Julian L; Lentz E; Nuechterlein KH; Perkins DO; Skale TG; Snowden LR; Tandon R; Tek C; Velligan D; Vinogradov S; O'Gorman C
    Schizophr Res; 2017 Jul; 185():137-143. PubMed ID: 28087270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metacognitive deficits predict future levels of negative symptoms in schizophrenia controlling for neurocognition, affect recognition, and self-expectation of goal attainment.
    Lysaker PH; Kukla M; Dubreucq J; Gumley A; McLeod H; Vohs JL; Buck KD; Minor KS; Luther L; Leonhardt BL; Belanger EA; Popolo R; Dimaggio G
    Schizophr Res; 2015 Oct; 168(1-2):267-72. PubMed ID: 26164820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Negative schizophrenic symptoms and their detection].
    Kukla F; Gold R
    Fortschr Neurol Psychiatr; 1991 Feb; 59(2):60-6. PubMed ID: 2026379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.